title: Commentary: What is the optimal PPI dosing following endoscopic haemostasis in acute ulcer bleeding?
authors.forename: G I
authors.initials: GI
authors.lastname: Leontiadis
authors.forename: A N
authors.initials: AN
authors.lastname: Barkun
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage*; D005260:Female; D016558:Hemostasis, Endoscopic / Q000379:methods*; D006801:Humans; D008297:Male; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D014662:Vasoconstrictor Agents